aivf.coCrawled Nov 5, 2026
AIVF provides an AI-driven platform for embryo evaluation, analytics, and embryology support in clinics and labs.
Blastocyst “pumping” is a detrimental feature predicting implantation failure: highly accurate assessment by computer vision analysis of time-lapse videos.
Unveiling the next generation of AI-based embryo evaluation for euploidy screening. AIVF Genetics introduces a pioneering, non-invasive AI tool aimed at refining the genetic quality assessment of embryos in IVF clinics.
This review summarizes clinical research presented by AIVF’s customers and partners at the ESHRE 41st Annual Conference 2025.
New artificial intelligence technology can improve IVF success rates by determining which embryos have the best chance of implantation.
AIVF’s Knowledge Center provides insights, articles, and resources on AI’s impact in IVF.
“AIVF is focused on commercial growth in Europe and intensive user research for future innovations.”
The World Economic Forum announces selection of the 100 most promising Technology Pioneers, companies that are tackling such issues as sustainability, climate change and healthcare.
AIVF replaces subjective analysis with data-driven decisions and automation in IVF.
AIVF shares updates on AI-powered tools and technologies in IVF treatments.
AIVF, a reproductive technology company based in Tel Aviv, Israel, aims to improve the odds. Its AI-powered embryo evaluation software, called EMA, is designed to process vast amounts of data — beyond what the human eye can detect — to simplify the embryo selection process.
AIVF uses AI-driven embryo grading to advance IVF treatments.
Reach out to AIVF for cutting-edge tech solutions. Connect with our team of experts and let's drive innovation together. Contact us today!
AIVF offers AI-powered IVF solutions to enhance the IVF journey. Harness the power of data and AI for better embryo grading and patient outcomes.
